A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms
MacroGenics
MacroGenics
Sumitomo Pharma America, Inc.
Celgene
Celldex Therapeutics
Indiana University
Tesaro, Inc.
Memorial Sloan Kettering Cancer Center
Duke University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Novacea